Ratings
0
Nobody has rated this yet. Be the first!
Works
9
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk
rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer
